%0 Journal Article %T Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting %A Joanna Stein-Fishbein %A Joshua C Berkowitz %A Keith S Sultan %A Richard Furie %A Sundas Khan %J Archive of "World Journal of Gastrointestinal Pharmacology and Therapeutics". %D 2018 %R 10.4292/wjgpt.v9.i1.8 %K Crohn¡¯s disease %K Ulcerative colitis %K Infliximab %K Azathioprine %K Inflammatory bowel disease %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797978/